Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Eli Lilly and Co
(NYSE:LLY)
597.95
Delayed Data
As of Dec 08
+9.68
/
+1.65%
Today’s Change
309.20
Today
|||
52-Week Range
629.97
+63.45%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest LLY News
|
Press Releases
3 Unstoppable Stocks to Buy Right Now
6:56am / MotleyFool.com - Paid Partner Content
An Important History Lesson for Gene-Editing Investors
Dec 02 / MotleyFool.com - Paid Partner Content
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
Dec 08 / Zacks.com - Paid Partner Content
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
Dec 02 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
Dec 08 / Zacks.com - Paid Partner Content
5 Top Stocks to Buy Before 2024
Dec 02 / MotleyFool.com - Paid Partner Content
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Dec 08 / MotleyFool.com - Paid Partner Content
Annovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why
Dec 01 / Zacks.com - Paid Partner Content
Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG
Dec 08 / Zacks.com - Paid Partner Content
1 Underrated Reason to Buy Eli Lilly Stock
Dec 01 / MotleyFool.com - Paid Partner Content
Will There Be a Recession in 2024?
Dec 07 / Zacks.com - Paid Partner Content
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Dec 01 / Zacks.com - Paid Partner Content
Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund?
Dec 07 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
Dec 01 / Zacks.com - Paid Partner Content
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
Dec 07 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
Nov 30 / Zacks.com - Paid Partner Content
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
Dec 07 / MotleyFool.com - Paid Partner Content
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
Nov 30 / MotleyFool.com - Paid Partner Content
Amgen: Relative Valuation Remains Unattractive
Dec 06 / GuruFocus News - Paid Partner Content
Alexandria (ARE), Eli Lilly to Expand Gateway Labs to San Diego
Nov 29 / Zacks.com - Paid Partner Content
Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now?
Dec 05 / Zacks.com - Paid Partner Content
4 Large Drug Stocks to Watch as IBD Market Gains Traction
Nov 29 / Zacks.com - Paid Partner Content
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca
Dec 04 / Zacks.com - Paid Partner Content
Is Invesco Large Cap Growth ETF (PWB) a Strong ETF Right Now?
Nov 29 / Zacks.com - Paid Partner Content
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
Dec 04 / Zacks.com - Paid Partner Content
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
Nov 29 / MotleyFool.com - Paid Partner Content
Altimmune (ALT) Rises 83% on Successful Phase II Obesity Study
Dec 04 / Zacks.com - Paid Partner Content
3 Large Drug Stocks That Have Outperformed Industry YTD
Nov 28 / Zacks.com - Paid Partner Content
1 Monster Dividend Stock Growth Investors Should Load Up On Right Now
Dec 04 / MotleyFool.com - Paid Partner Content
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Nov 28 / Zacks.com - Paid Partner Content
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Dec 04 / MotleyFool.com - Paid Partner Content
3 Top Stocks That'll Make Smart Investors Rich
Nov 27 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II
Dec 04 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce
Nov 27 / Zacks.com - Paid Partner Content
3 No-Brainer Growth Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content